So the news last night said that Trump made over $450 million on this. He did all this, while leaving everyone here, holding the bag. Master at pump and dump. Face it , he fucked every investor here.
vitamin890
Posts
-
-
Hahahahahahaha
-
Surfer, I disagree with your entire post. First of all, your a short, and only care if the stock goes down. Pipeline is pretty strong, Advair, & insulin should both be out within the next 24 months, with Advair within the next 12 months. Two more bronchial products, and an additional insulin product within the next 3-5 years. Not too shabby of a pipeline. Plenty of cash, with over 100 million on hand, plus a 30 million dollar tax refund coming any day. Very little chance of bankruptcy. Delisting wouldn’t be great, but the company would save quite a bit of money, by not paying the crazy fees NYSE charges. With that being said, I still have faith in LCI turning around
-
Their problem is the nearly 3 billion in debt. It’s going to continue to strangle them. With rates moving up, it’s going to be a bigger problem in the future
-
Gonna miss, and miss big. Entire industry is in turmoil, and these guys aren’t gonna go against the downward trend. Way too much debt, with lower sales, and lower profit margin. This is a two dollar stock.
-
Not only has Tim never sold any stock, Pat ( the COB) or the Farber’s haven’t either. These people are committed to seeing this through.
-
I don’t think it’s as bad as it looks. Not that it helps, but it’s an industry wide problem. The good news, is Lannett saw this coming, and is working on some very large products. Bio similar products are their future, and they’re only months away from possibly launching their first one.
-
Bottom line, they get Advair, then insulin, or it’s done. If they get the those, we will be better than hood, if they don’t, than I guess it’s over. The hood news, is they feel optimistic on those two.
-
They just announced the filing for insulin. Hoping to launch early 24
-
I believe they should be filing the insulin application any day. Launch hopefully within 24 months after that. Advair is filed with a probable launch in 6-12 months. Probably in the nine month area.
-
Answer to your questions. The lawsuits don’t seem to be an issue. Little to no exposure n the opioids, the price fixing legal issue has been going on for years, and appears to be going nowhere. They should be getting Advair within the next 6-12 months, with several hundred million in sales, and insulin in the next two years. Sky’s the limit.
-
It was founded in 1942, it’s almost 80 years old. They are in the process of reinventing themselves, and slowly becoming a bio company. Within the next five years, they could be a multi billion dollar company. This is just a buying opportunity.
-
The word is seeking!! Firms will have a hard time investing money into this, way too political, and it will scare of half their investors. No way are they gonna be able to raise 1/10 of what they want
-
I don’t think they need me management. Tim said that this turnaround will take time, and he’s closing in on the biggest product in company history. If Tim is correct, Lannett will be launching Advair, in less than a year. Possibly a 500 million dollar product for Lannett. If he’s also correct, insulin will be in 24, with two or three huge products just a few years later. If they were quick and easy, there would be tons of competition. The thought is, large hard to produce items, with minimal competition. This takes time, and they are almost there. The sell off if shorts beating this down, and loss of patience.
-
They should have named it, The Full of Shit Network, that would be truthful!!!
-
Pretty funny!! If it has Trumps name on it, it sucks!! Only losers would invest in a loser!!
-
Hahahahaha
-
At this rate, they will be able to buy 20% of the outstanding shares for only 10% of their cash, if they just wait till next week. I do agree though, a stock buyback makes total sense.
-
I don’t think they will sell. This is all about Advair now. If they launch Advair as planned, this stock should be north of 20, if they don’t, we’re fucked, plain and simple. A buyer wouldn’t pay over 6 or 7 a share, if we’re lucky, and I don’t see that happening.
DWAC
DWAC
LCI
AMRX
AMRX
LCI
LCI
LCI
LCI
LCI
LCI
LCI
LCI
DWAC
LCI
DWAC
DWAC
DWAC
LCI
LCI